Evidence map›Paper›PMID 33855081›Full record

ArticleBioMed research international2021

Antitumor Effect of

Ouadie Mohamed El Yaagoubi, Ayoub Lahmadi, Abdelhakim Bouyahya, Hassan Filali, Hamid Samaki, Said El Antri, Souad Aboudkhil

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Camel Milk in Skin Cancer Therapeutics: AnAnti-cancer agents in medicinal chemistry · 2026
    Article
  3. Article
  4. Review
  5. Methanolic Extracts ofInternational journal of molecular sciences · 2023
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ouadie Mohamed El YaagoubiLaboratory of Biochemistry, Environment and Agri-Food (URAC 36), Faculty of Sciences and Techniques-Mohammedia, Hassan II University, Casablanca, Morocco.ORCID https://orcid.org/0000-0003-2018-5877
Ayoub LahmadiLaboratory of Biochemistry, Environment and Agri-Food (URAC 36), Faculty of Sciences and Techniques-Mohammedia, Hassan II University, Casablanca, Morocco.ORCID https://orcid.org/0000-0002-0849-0038
Abdelhakim BouyahyaLaboratory of Human Pathologies Biology, Department of Biology, Faculty of Sciences, Mohammed V University, Rabat, Morocco.ORCID https://orcid.org/0000-0001-9317-1631
Hassan FilaliLaboratory of Biochemistry, Environment and Agri-Food (URAC 36), Faculty of Sciences and Techniques-Mohammedia, Hassan II University, Casablanca, Morocco.ORCID https://orcid.org/0000-0002-4265-0066
Hamid SamakiNational Institute of Social Action (INAS), Tangier, Morocco.ORCID https://orcid.org/0000-0002-7016-8525
Said El AntriLaboratory of Biochemistry, Environment and Agri-Food (URAC 36), Faculty of Sciences and Techniques-Mohammedia, Hassan II University, Casablanca, Morocco.ORCID https://orcid.org/0000-0003-3534-2476
Souad AboudkhilLaboratory of Biochemistry, Environment and Agri-Food (URAC 36), Faculty of Sciences and Techniques-Mohammedia, Hassan II University, Casablanca, Morocco.ORCID https://orcid.org/0000-0001-5666-0970
University of Hassan II Casablanca · MAMohammed V University · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this work is to evaluate the antitumor effect mediated by the proteasome inhibitors of

Indexed as

9,10-Dimethyl-1,2-benzanthraceneAnimalsAntineoplastic AgentsCaco-2 CellsChymotrypsinDrug Evaluation, PreclinicalFemaleHumansInulaMiceMolecular Docking SimulationPapillomaPlant ExtractsProteasome Endopeptidase ComplexProteasome InhibitorsSkin Neoplasms9,10-Dimethyl-1,2-benzanthraceneAntineoplastic AgentsChymotrypsinPlant ExtractsProteasome Endopeptidase ComplexProteasome Inhibitors

Identifiers

PMID33855081
PMCPMC8019636
OpenAlexW3143332400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.